EMCrit Project
JUNE 1, 2024
intro: the challenge of procedural sedation in critical illness Procedural sedation for critically ill patients is a minefield for several reasons: Patients are already physiologically unstable. Procedures are emergent (a factor widely associated with greater complications). Time constraints often prevent a complete pre-anesthetic evaluation (e.g., medical history and laboratory studies may be unknown).
Express Pharma
JUNE 1, 2024
Pharmaceutical companies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. However, these technologies, while being beneficial, introduce significant cybersecurity risks that need to be managed effectively. The rise in cyber threats, including ransomware and phishing, threatens sensitive data related to clinical trials, patents, and patient information, potentially eroding customer trust
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
JUNE 1, 2024
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Slovakia.
The Happy PharmD
JUNE 1, 2024
In a recent conversation with one of our clients, Katie Lozano, she shared a story that resonates deeply with the experiences of many pharmacists navigating their careers today. Katie had been with her company for seven years when it was acquired by a larger corporation. Over time, she noticed a significant shift in the company culture, with an increasing emphasis on numbers and less attention to employee well-being.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Drug Patent Watch
JUNE 1, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five… Source
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
JUNE 1, 2024
Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs.
PharmaTech
JUNE 1, 2024
CGT Catapult will implement Cellular Origins' robotic platform in its Stevenage, UK, site to establish automated CGT manufacturing.
Drug Patent Watch
JUNE 1, 2024
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier.
The Happy PharmD
JUNE 1, 2024
In today’s discussion, we’re diving into the world of pharmacist sign-on bonuses—those enticing offers that promise a substantial sum upfront to lure pharmacists into high-demand positions, especially in retail settings. Over the years, sign-on bonuses have made a significant comeback, especially since the easing of the pandemic’s grip in 2022.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JUNE 1, 2024
This is the largest dataset of pregnancy outcomes for an anti-CD20 therapy in MS, enabling a more comprehensive understanding of ocrelizumab’s safety.
Pharmacy Times
JUNE 1, 2024
In addition to medication management, pharmacists are educating patients and helping them navigate the complex medical system.
Pharmacy Times
JUNE 1, 2024
The addition of ribociclib (Kisqali; Novartis) to endocrine therapy demonstrated a 28% risk reduction in invasive disease-free survival.
Expert insights. Personalized for you.
136 
Let's personalize your content